Mission
Iran Pharmis' Mission is to supply the markets we participate in with the products and services which enables people to have the chance of enjoying their life again. In this path, we sometimes take the direct way of providing the products that are just made for achieving this goal (e.g. in products and services related to Wound, Ostomy, and Incontinence Therapy, and so forth) and sometimes our products help others to help us achieve this goal (by supplying products such as Surgical Gloves, or Surgical Tapes).


History
Below is some information on Iran Pharmis History of Operations, and some of the Milestones it has achieved:


1979: Iran Pharmis is founded in this year. It is incorporated by Mr. Manouchehr Soltani as the founder aiming to become a leading trading company in the Healthcare Industry in Iranian Territory.


1982: Iran Pharmis Started importing its first Disposable Medical Products by importing Sterile Needles.


1985: Iran Pharmis started working on the products of Kawamoto Corporation, a Japanese supplier of Disposable Medicals & Surgical Tapes; importing KBM Surgical Tape.


1987: Iran Pharmis initiated importing of Stoma Bags from Coloplast. From this time till 19 years later Iran Pharmis was the sole agent of Coloplast in Iranian Market.


1990: Iran Pharmis tried to enter the advanced wound care market by importing the related Coloplast Products. However, due to the Economic Conditions of Iran at the time, this became a failed attempt.
With the new Economic Powers emerging, Iran Pharmis started working with Chinese Suppliers, and Meheco was the main supplier of Iran Pharmis' Chinese Products at this time.


1991: Mr. Manoucher Soltani, Iran Pharmis' founder, left the company. He departed to spend most of his time on a Shampoo Manufacturing company which was growing very fast by this time and which he was a shareholder & executive of.
Mr. Abbas Barati joined Iran Pharmis.


1993: Iran Pharmis renewed its agreement with Coloplast.


1997: Comfeel branded products, manufactured by Coloplast, as the first series of advanced woundcare products in Iran were imported to Iran through Iran Pharmis; Iran Pharmis's marketing team started educating the market over using the Advanced Wound Care Products.


2001: Iran Pharmis, Teb Novin, and a couple of other companies merged to form "Novin Group" which became the largest private company in Iran working on disposables


2005: Iran Pharmis with Novin Group purchased 51% of shares of a start-up company, Darou Darman Pars (DDP), and they entered into the pharmaceutical supply industry with this acqusition.


2006: Iran Pharmis along with Novin Group received the national distribution authorization for pharmaceutical products in this year (as the government started to allow private companies to also enter this sector). This distribution company which was also distributing disposables medicals formed in order to get the so-called products to the pharmacies and hospitals making them available in all over the country.


2007: Mr. Fereidoon Soltani, a member of the management team, left the company after 27 years of cooperation along with his son, Bahram. They formed a new company along with new partners, and Iran Pharmis' 20 years of cooperation with Coloplast got terminated in this year.


2008: Iran Pharmis and Teb Novin started distribution of Smith & Nephew's Advanced Wound Care Products through an exclusive contract with the Jalal Ara Co., the exclusive agent of the S&N's Advanced Wound Care Products in Iran.


2009: Management Team of Iran Pharmis and Novin Group separated in order to operate under the independant names of Iran Pharmis and Teb Novin; working on Disposable Medicals and Pharmaceuticals respectively.
Iran Pharmis is now working independantly again after 8 years of working along with the Teb Novin Company.


2010: Iran Pharmis separated its sales units into two major divisions which are general items and professional items. The general items will be targeting the low-end of the Iranian Market, and the professional items are targeting the high-end of the market. This became an avoidable strategy as the company's portfolio grew further and as the gap the Iranian Consumer Sector widend. This shift has become a huge growth contributing factor. The low-end targeted division will be operating as a fully subsidiary company called Tamin Salamat.